Epidemiology and Infectious Diseases. Current Items
ISSN 2226-6976 (Print)
ISSN 2414-9640 (Online)
Menu
Archives
Home
About the Journal
Editorial Policies
Author Guidelines
About the Journal
Issues
Search
Current
Retracted articles
Archives
Contact
Subscriptions
Editorial Board
All Journals
User
Username
Password
Remember me
Forgot password?
Register
Notifications
View
Subscribe
Subscription
Login to verify subscription
Search
Search
Search Scope
All
Authors
Title
Abstract
Index terms
Full Text
Browse
By Issue
By Author
By Title
Other Journals
Categories
Keywords
COVID-19
HIV infection
SARS-CoV-2
antibiotic resistance
antiretroviral therapy
antiviral therapy
children
chronic hepatitis C
epidemic process
epidemiological surveillance
epidemiology
healthcare-associated infections
incidence
influenza
morbidity
mortality
prevalence
prevention
treatment
tuberculosis
vaccination
×
User
Username
Password
Remember me
Forgot password?
Register
Notifications
View
Subscribe
Subscription
Login to verify subscription
Search
Search
Search Scope
All
Authors
Title
Abstract
Index terms
Full Text
Browse
By Issue
By Author
By Title
Other Journals
Categories
Keywords
COVID-19
HIV infection
SARS-CoV-2
antibiotic resistance
antiretroviral therapy
antiviral therapy
children
chronic hepatitis C
epidemic process
epidemiological surveillance
epidemiology
healthcare-associated infections
incidence
influenza
morbidity
mortality
prevalence
prevention
treatment
tuberculosis
vaccination
Home
>
Search
>
Author Details
Author Details
Kanestri, V. G
Issue
Section
Title
File
No 3 (2012)
Articles
THE NOVEL HIV NON-NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITOR RILPIVIRINE: A REVIEW OF INTERNATIONAL CLINICAL TRIALS
No 1 (2013)
Articles
USE OF THE FUSION INHIBITOR ENFUVIRTIDE IN ANTIRETROVIRAL THERAPY REGIMENS FOR HIV-INFECTED PATIENTS
No 2 (2013)
Articles
THE HEPATITIS C VIRUS PROTEASE INHIBITOR TELAPREVIR IN THERAPY REGIMENS FOR CHRONIC HEPATITIS C IN PATIENTS WITH HIV INFECTION
No 6 (2014)
Articles
DUAL ANTIRETROVIRAL THERAPY WITH LOPINAVIR AND RITONAVIR
No 1 (2015)
Articles
A fixed-dose combination of abacavir/lamivudine as a nucleoside basis for first-line antiretroviral therapy regimens
No 2 (2015)
Articles
EFFICACY AND SAFETY OF ANTIRETROVIRAL THERAPY REGIMENS CONTAINING ETRAVIRINE FOR HIV-INFECTED PATIENTS
No 6 (2015)
Articles
HIV drug resistance: Dolutegravir is a second-generation HIV integrase inhibitor
No 2 (2016)
Articles
Use of non-boosted atazanavir in clinical practice
No 2 (2011)
Articles
THE HIV NUCLEOSIDE REVERSE TRANSCRIPTASE INHIBITORS ABACAVIR AND LAMIVUDINE IN FIRST-LINE ANTIRETROVIRAL THERAPY REGIMENS
This website uses cookies
You consent to our cookies if you continue to use our website.
About Cookies
TOP